報價延遲最少15分鐘:2025/07/07 00:44 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
31.01 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.09/2.75
|
|
企業價值
26.59B
|
| 資產負債 |
|
每股賬面淨值
13.80
|
| 現金流量 |
|
現金流量率
0.04
|
| 損益表 |
|
收益
14.81B
|
|
每股收益
29.78
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/07 00:44 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025. |